| Peroxiredoxin-2 represses NRAS-mutated melanoma cells invasion by modulating EMT markers IHY Noma, LA da Costa Carvalho, DEM Camarena, RO Silva, ... Biomedicine & Pharmacotherapy 177, 116953, 2024 | | 2024 |
| Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study A Gault, L Hogarth, KC Williams, A Greystoke, N Rajan, A Speight, ... BMC cancer 24 (1), 733, 2024 | | 2024 |
| Systemic Inflammation, the Peripheral Blood Transcriptome, and Primary Melanoma J Randerson-Moor, J Davies, M Harland, J Nsengimana, T Bigirumurame, ... Journal of Investigative Dermatology, 2024 | | 2024 |
| Immune subtyping of melanoma whole slide images using multiple instance learning L Godson, N Alemi, J Nsengimana, GP Cook, EL Clarke, D Treanor, ... Medical Image Analysis 93, 103097, 2024 | 6 | 2024 |
| The tumor suppressive role of methylthioadenosine phosphorylase in melanoma JJ Hsiao, P Andreu-Perez, LV Kemény, M Hejna, J Nsengimana, ... Cancer Research 84 (6_Supplement), 3020-3020, 2024 | | 2024 |
| Topical corticosteroids stimulate T cell-dependent melanoma growth control CH Earnshaw, SC Chiang, A Moeini, M Koufaki, E Bonavita, L Nebot-Bral, ... Cancer Research 84 (6_Supplement), 2647-2647, 2024 | | 2024 |
| Multi-level Graph Representations of Melanoma Whole Slide Images for Identifying Immune Subgroups L Godson, N Alemi, J Nsengimana, GP Cook, EL Clarke, D Treanor, ... International Conference on Medical Image Computing and Computer-Assisted …, 2023 | | 2023 |
| GABA regulates electrical activity and tumor initiation in melanoma M Tagore, E Hergenreder, SC Perlee, NM Cruz, L Menocal, S Suresh, ... Cancer Discovery 13 (10), 2270-2291, 2023 | 10 | 2023 |
| Utilising high-dimensional data in randomised clinical trials: A review of methods and practice S Cherlin, T Bigirumurame, MJ Grayling, J Nsengimana, L Ouma, ... Research Methods in Medicine & Health Sciences, 26320843231186399, 2023 | | 2023 |
| ROR2 promotes epithelial-mesenchymal transition by hyperactivating ERK in melanoma MV Castro, GA Barbero, P Máscolo, MB Villanueva, J Nsengimana, ... Journal of Cell Communication and Signaling 17 (1), 75-88, 2023 | 4 | 2023 |
| Identifying the transcriptional drivers of metastasis embedded within localized melanoma S Suresh, R Rabbie, M Garg, D Lumaquin, TH Huang, E Montal, Y Ma, ... Cancer discovery 13 (1), 194-215, 2023 | 7 | 2023 |
| Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk C Grasso, M Popovic, E Isaevska, F Lazzarato, V Fiano, D Zugna, J Pluta, ... Cancer Epidemiology, Biomarkers & Prevention 31 (9), 1769-1779, 2022 | 5 | 2022 |
| Defining novel causal SNPs and linked phenotypes at melanoma-associated loci C Castaneda-Garcia, V Iyer, J Nsengimana, A Trower, A Droop, ... Human Molecular Genetics 31 (17), 2845-2856, 2022 | 4 | 2022 |
| Tumour gene expression signature in primary melanoma predicts long-term outcomes (vol 12, 1137, 2021) M Garg, DL Couturier, J Nsengimana, NA Fonseca, M Wongchenko, ... NATURE COMMUNICATIONS 13 (1), 2022 | | 2022 |
| Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes M Garg, DL Couturier, J Nsengimana, NA Fonseca, M Wongchenko, ... Nature Communications 13 (1), 2841, 2022 | | 2022 |
| Genes regulated by DNA methylation are involved in distinct phenotypes during melanoma progression and are prognostic factors for patients DDA Papaiz, FE Rius, ALP Ayub, CS Origassa, H Gujar, DO Pessoa, ... Molecular Oncology 16 (9), 1913-1930, 2022 | 2 | 2022 |
| Ulcerated melanoma: systems biology evidence of inflammatory imbalance towards pro‐tumourigenicity J Davies, S Muralidhar, J Randerson‐Moor, M Harland, S O’Shea, J Diaz, ... Pigment Cell & Melanoma Research 35 (2), 252-267, 2022 | 5 | 2022 |
| Weakly-supervised learning for image-based classification of primary melanomas into genomic immune subgroups L Godson, N Alemi, J Nsengimana, GP Cook, EL Clarke, D Treanor, ... arXiv preprint arXiv:2202.11524, 2022 | 1 | 2022 |
| ROR2 has a protective role in melanoma by inhibiting Akt activity, cell-cycle progression, and proliferation MV Castro, GA Barbero, MB Villanueva, L Grumolato, J Nsengimana, ... Journal of Biomedical Science 28, 1-15, 2021 | 12 | 2021 |
| ROR2 Promotes EMT and Necrosis by Hyperactivating ERK in Melanoma MV Castro, G Barbero, MB Villanueva, J Nsengimana, J Newton-Bishop, ... | | 2021 |
